Literature DB >> 26063946

Anti-chlamydial IgG Neutralizing Ability in Nonzoonotic Atypical Community Acquired Respiratory Tract Infections.

Salvatore Pignanelli1, Giovanna Pulcrano2, Vita Dora Iula2, Alisa Shurdhi3.   

Abstract

Chlamydophila pneumoniae is a pathogenic agent, involved in various types of infection. This study has evaluated the ability of IgG antibodies in outpatient, with acute respiratory tract infections from C. pneumoniae, to neutralize in vitro purified elementary bodies of this bacterium, revealing a good neutralizing performance of IgG antibodies.

Entities:  

Keywords:  Chlamydophila pneumoniae; EBs; IgG; Neutralizing activity

Year:  2015        PMID： 26063946      PMCID： PMC4456498          DOI： 10.1007/s12088-015-0527-7

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN： 0046-8991            Impact factor:   2.461


  15 in total

1.  In vitro activity of rifaximin against Chlamydia suis.

Authors:  S Pignanelli; A Shurdhi
Journal:  Vet Rec       Date:  2011-10-06       Impact factor: 2.695

2.  Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection.

Authors:  Paolo Busatto; Francesco Blasi; Francesca Casanova; Carlo Selmi; Stefano Centanni; Massimo Zuin
Journal:  J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 4.029

3.  In vitro detection of neutralising antibodies to Chlamydia suis in pig sera.

Authors:  M Donati; A Di Francesco; R Baldelli; S Magnino; S Pignanelli; A Shurdhi; F Delucca; R Cevenini
Journal:  Vet Rec       Date:  2009-02-07       Impact factor: 2.695

4.  Simultaneous use of direct and indirect diagnostic techniques in atypical respiratory infections from Chlamydophila pneumoniae and Mycoplasma pneumoniae.

Authors:  S Pignanelli; A Shurdhi; F Delucca; M Donati
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

5.  Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies.

Authors:  D Baud; L Regan; G Greub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-28       Impact factor: 3.267

6.  Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis.

Authors:  M C Phoon; Gabriel W J Yee; Woon-Puay Koh; Vincent T K Chow
Journal:  Indian J Microbiol       Date:  2011-02-16       Impact factor: 2.461

Review 7.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions.

Authors:  Candice M Mitchell; Susan Hutton; Garry S A Myers; Robert Brunham; Peter Timms
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

9.  In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in Northern and Southern Italy.

Authors:  Salvatore Pignanelli; Giovanna Pulcrano; Vita Dora Iula; Patrizia Zaccherini; Antonio Testa; Maria Rosaria Catania
Journal:  APMIS       Date:  2013-09-30       Impact factor: 3.205

10.  Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.

Authors:  Erika Bartolini; Elvira Ianni; Elisabetta Frigimelica; Roberto Petracca; Giuliano Galli; Francesco Berlanda Scorza; Nathalie Norais; Donatello Laera; Fabiola Giusti; Andrea Pierleoni; Manuela Donati; Roberto Cevenini; Oretta Finco; Guido Grandi; Renata Grifantini
Journal:  J Extracell Vesicles       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.